For the Inventor, By the Inventor

Enter assignee name

Centre Leon Berard

USPTO Granted Patents = 34

CIPO Patents = 1

EPO Patents = 32

Forward Citations = 66

Loading Chart...

Loading Chart...

78 inventors (with patents filed for the assignee):

Christine Menetrier-Caux (9 out of 9 patents)

Daniel Olive (8 out of 28 patents)

Christophe Caux (7 out of 14 patents)

4. Julien Faget (6 out of 6 patents)

5. Jacques Nunes (6 out of 7 patents)

6. Cyril Lafon (4 out of 13 patents)

7. Toufic Renno (3 out of 3 patents)

8. Isabelle Coste-Invernizzi (3 out of 3 patents)

9. Serge Lebecque (3 out of 3 patents)

10. Jean-Yves Chapelon (3 out of 31 patents)

11. Stefan Catheline (3 out of 4 patents)

12. Jean-Louis Mestas (3 out of 3 patents)

13. Rémi Souchon (3 out of 4 patents)

14. Stéphane Giraud (2 out of 2 patents)

15. William Apoutou N'Djin (2 out of 3 patents)

34 patents: Sort by Forward Citations

1. 12509465 - Benzoimidazole derivatives as anticancer agents (2025-12-30),

2. 12462371 - Computer-implemented method and apparatus for characterizing a flexible tube (2025-11-04),

3. 12440185 - Method for determining a mechanical property of a layered soft material (2025-10-14),

4. 12433838 - Liposomal formulation of bacterial lipopolysaccharide combined with a cytotoxic agent, and use thereof in anti-tumour therapy (2025-10-07),

5. 12371402 - Mitochondrial activity inhibitors targeting tumoral metabolism (2025-07-29),

6. 12249073 - Systems and methods for mesothelioma feature detection and enhanced prognosis or response to treatment (2025-03-11),

7. 12245892 - Method and apparatus for imaging in real time the propagation of a mechanical wave in an acoustically propagative material (2025-03-11),

8. 12162932 - Combined treatment with Netrin-1 interfering drug and immune checkpoint inhibitors drugs (2024-12-10),

9. 12140594 - Early and non invasive method for assessing a subject's risk of having pancreatic ductal adenocarcinoma and methods of treatment of such disease (2024-11-12),

10. 11801400 - Therapy apparatus for treating tissue by the emission of remote crossed focused ultrasound waves (2023-10-31),

11. 11740243 - Early and non invasive method for assessing a subject's risk of having pancreatic ductal adenocarcinoma and methods of treatment of such disease (2023-08-29),

12. 11602327 - Method and system for localizing a region of interest in a medium in which cavitation occurs (2023-03-14),

13. 11589838 - Method and apparatus for determining local acoustic field intensity within a soft solid (2023-02-28),

14. 11555191 - Inhibitor for use for preventing and/or treating an infection with hepatitis B virus (2023-01-17),

15. 11540806 - Device and system for generating ultrasonic waves in a target region of a soft solid and method for locally treating a tissue (2023-01-03),

The Centre Léon Bérard is a comprehensive cancer center located in Lyon, France. It is one of the largest cancer centers in Europe, providing a wide range of specialized medical services, research, and education related to cancer treatment. With a multidisciplinary team of healthcare professionals, the center offers innovative and personalized care to patients, combining cutting-edge technology with a patient-centric approach. The Centre Léon Bérard is committed to advancing cancer research, collaborating with national and international institutions to develop new treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

34 Patents

#10 in Lyons

#636 in France

#19,058 in the World

Centre Leon Berard

Forward Citations = 66

78 inventors:

Christine Menetrier-Caux (9 out of 9 patents)

Daniel Olive (8 out of 28 patents)

Christophe Caux (7 out of 14 patents)

4. Julien Faget (6 out of 6 patents)

5. Jacques Nunes (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…